Palliative care assessment of dry mouth: what matters most to patients with advanced disease?

被引:30
作者
Fleming, Michelle [1 ]
Craigs, Cheryl L. [1 ]
Bennett, Michael I. [1 ]
机构
[1] Univ Leeds, Leeds Inst Hlth Sci, Acad Unit Palliat Care, Leeds LS2 9JT, W Yorkshire, England
关键词
Dry mouth; Xerostomia; Palliative care; Advanced disease; Assessment; Cross-sectional study; ANTICHOLINERGIC LOAD; ARTIFICIAL SALIVA; XEROSTOMIA; PILOCARPINE; MANAGEMENT; HOSPICE;
D O I
10.1007/s00520-019-04908-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Dry mouth is a highly prevalent and significant symptom in patients with advanced progressive diseases. It is a poorly understood area of research, and currently, there is no standardised outcome measure or assessment tool for dry mouth. Methods To assess responses to self-reported dry mouth questions, the impact of dry mouth, methods used to reduce symptoms and relevance of the questionnaire. A cross-sectional multisite study of 135 patients with advanced progressive disease experiencing dry mouth. Participants were located in the inpatient, day care, outpatient or community setting. Results The majority (84.4%) of patients rated their dry mouth as moderate or severe using the verbal rating scale (VRS). Seventy-five percent (74.7%) had a numeric rating scale (NRS) score of 6 or more for dry mouth severity. Patients reported that dry mouth interfered most with talking and was the most important function to assess (median score 6 out of 10) followed by eating (median 5) and taste (median 5). Taking sips of drink was the most common and most effective self-management strategy. Over half of patients (54.6%) also reported impact on swallow and sleep and associated dryness of lips, throat and nasal passages. Conclusions This study highlights the severity of dry mouth in advanced disease. Important factors when assessing patients with dry mouth should include the functional impact on day-to-day activities including talking, dysphagia and sleep. Simple considerations for patients include provision of drinks and reviewing medications. This study could be used to develop a standardised assessment tool for dry mouth to use in clinical practice.
引用
收藏
页码:1121 / 1129
页数:9
相关论文
共 29 条
[1]  
Abernethy Amy P, 2005, BMC Palliat Care, V4, P7
[2]   Changes in anticholinergic load from regular prescribed medications in palliative care as death approaches [J].
Agar, M. ;
Currow, D. ;
Plummer, J. ;
Seidel, R. ;
Carnahan, R. ;
Abernethy, A. P. .
PALLIATIVE MEDICINE, 2009, 23 (03) :257-265
[3]  
[Anonymous], COCHRANE DATABASE SY
[4]   EFFECTS OF FUROSEMIDE ON THE ORAL CAVITY [J].
ATKINSON, JC ;
SHIROKY, JB ;
MACYNSKI, A ;
FOX, PC .
GERODONTOLOGY, 1989, 8 (01) :23-26
[5]   Using the modified Barthel index to estimate survival in cancer patients in hospice: observational study [J].
Bennett, M ;
Ryall, N .
BRITISH MEDICAL JOURNAL, 2000, 321 (7273) :1381-1382
[6]   The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity [J].
Carnahan, Ryan M. ;
Lund, Brian C. ;
Perry, Paul J. ;
Pollock, Bruce G. ;
Culp, Kennith R. .
JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 46 (12) :1481-1486
[7]   A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer [J].
Davies, AN .
PALLIATIVE MEDICINE, 2000, 14 (03) :197-203
[8]   A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer [J].
Davies, AN ;
Daniels, C ;
Pugh, R ;
Sharma, K .
PALLIATIVE MEDICINE, 1998, 12 (02) :105-111
[9]   Xerostomia in patients with advanced cancer [J].
Davies, AN ;
Broadley, K ;
Beighton, D .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 22 (04) :820-825
[10]   PILOCARPINE TREATMENT OF SALIVARY-GLAND HYPOFUNCTION AND DRY MOUTH (XEROSTOMIA) [J].
FOX, PC ;
ATKINSON, JC ;
MACYNSKI, AA ;
WOLFF, A ;
KUNG, DS ;
VALDEZ, IH ;
JACKSON, W ;
DELAPENHA, RA ;
SHIROKY, J ;
BAUM, BJ .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (06) :1149-1152